<html>
<head>PUBMED IDs for OPGL</head>
<body bgcolor='#C5F0F2'><h1>OPGL</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9568710/'>Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.</a> May 6  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9568705/'>Vitamin D receptor gene polymorphisms influence insulin secretion in Bangladeshi Asians.</a> May 6  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9568704/'>Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African-American subjects.</a> May 6  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9703989/'>Osteoprotegerin mRNA is increased by interleukin-1 alpha in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells.</a> August 15  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/10097072/'>Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.</a> March 31  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10585776/'>Characterization of TNFRSF19, a novel member of the tumor necrosis factor receptor superfamily.</a> December 10  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10637272/'>Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.</a> January 19  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10702390/'>Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation.</a> March 7  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10862785/'>IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion.</a> June 23  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10862780/'>Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective?</a> June 23  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10865206/'>Osteoclast lineage commitment of bone marrow precursors through expression of membrane-bound TRANCE.</a> June 24  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/10874596/'>Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis.</a> June 30  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11375772/'>Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption.</a> May 29  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11444846/'>Macrophage colony-stimulating factor suppresses osteoblast formation.</a> July 11  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11804028/'>Evidence that the rat osteopetrotic mutation toothless (tl) is not in the TNFSF11 (TRANCE, RANKL, ODF, OPGL) gene.</a> January 24  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/14696966/'>Perspective. Osteoclastogenesis and growth plate chondrocyte differentiation: emergence of convergence.</a> December 31  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15514587/'>Gene expression in giant-cell tumors.</a> October 30  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15514524/'>Transfusion-induced leukocyte IL-8 gene expression is avoided by the use of human polymerized hemoglobin.</a> October 30  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15514522/'>Blood transfusion is associated with donor leukocyte microchimerism in trauma patients.</a> October 30  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/19940926/'>Central control of fever and female body temperature by RANKL/RANK.</a> January 14  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21445556/'>RANKL/RANK-beyond bones.</a> October 18  2011<br></body></html>
